SALT studie – Stadiëring met [18F]PSMA PET voorafgaand aan lymfeklierdissectie bij patiënten met een prostaattumor

Staging with [18F]PSMA PET prior to Lymph node dissection in patients with prostatic Tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26080

Enrollment

100

Registered

2018-11-13

Start date

2017-11-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary prostate cancer

Interventions

Preoperative [18F]DCFPyL PET/CT

Eligibility

Inclusion criteria

Inclusion criteria: Histologically confirmed prostate cancer; planned voor radicale prostatectomy in combination with an ePLND;

Exclusion criteria

Exclusion criteria: multiple malignancies; claustrophobia

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy of [18F]DCFPyL PET/CT for pelvic lymph nodes (sensitivity, specificity, PPV, NPV)	—

Secondary

Measure	Time frame
Diagnostic accuracy of [18F]DCFPyL PET/CT for distant metastases (PPV)	—

Contacts

Public ContactBernard Jansen

bh.jansen@vumc.nl+31-20-44446033

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)